Konferenzen  >  Biowissenschaften  >  Molekularbiologie  >  Virtuelle Veranstaltung

The European Association for Cancer Research (EACR)

This conference will explore the fundamental mechanisms controlling cancer cell plasticity at multiple biological levels including the epigenome, transcriptome, metabolome, and cellular microenvironment. Our panel of expert speakers will also discuss innovative approaches to target cell plasticity using novel pharmacological interventions that aim to prevent or reverse the adaptive mechanisms cancer cells use to circumvent conventional therapies.

Chris Iliffe (Conference Officer);     Tel.: [N/A];     Email: christopher.iliffe@eacr.org

cancer research, oncology, cancer cell biology, cancer cell plasticity, cancer epigenetics, cellular microenvironment, tumour microenvironment, tumour heterogeneity, cancer transcriptomics, metabolic reprogramming in cancer, phenotypic changes in cancer, cancer progression, cancer therapy resistance, virtual academic conference

Onkologie,    Translationale Medizin, Klinische Studien

The European Association for Cancer Research (EACR)

This conference will explore a seemingly paradoxical approach to cancer therapy: the deliberate hyper-activation of cancer-relevant signalling pathways. Accumulating evidence suggests that this leads to cell death caused by a further activation of cellular stress responses. Such an approach could revolutionise treatment strategies, which often cannot abate the return of resistance in advanced cancers caused by secondary mutations reactivating previously inhibited pathways. Join us on 20 and 21 January 2026 to learn the latest science in this field from our panel of globally renowned experts. They will teach you about ways to hyperactivate oncogenic signalling and how the vulnerabilities associated with this state can be identified. In doing so, you’ll gain a fundamentally different perspective on ways to treat cancer. If you work in this field, send us an abstract before 17 November 2025 for a chance to have your work featured as a Proffered Paper or in a Flash Talk presentation! Registration closes on 15 December 2025.

Conference Officer: Chris Iliffe;     Tel.: [N/A];     Email: christopher.iliffe@eacr.org

cancer research, oncology, inhibiting oncogenic signalling, cancer therapy resistance mechanisms, secondary mutations in cancer, novel cancer therapy approaches, hyperactivation of signalling pathways, vulnerabilities within hyperactivated cancer cells, drug application, novel target identification

The European Association for Cancer Research (EACR)

This conference will focus on the basic mechanisms controlling cancer cell signalling circuits at the transcriptome, proteome and phosphoproteome levels, as well as emerging concepts in cancer cell signalling and cutting-edge, OMICS-based insights. Despite decades of research, our global understanding of how cancer cell signalling circuits are controlled, and how they determine cancer progression and therapy resistance, is still far from complete. Join us online on 10 and 11 February 2026 to hear the latest science in this area from a panel of global experts. If you work in this field, submit an abstract before 15 December 2025 for a chance to have your work featured as a Proffered Paper or in a Flash Talk presentation. Register by 19 January 2026 to secure your place as a participant.

Conference Officer: Hannah Barrs;     Email: hannah.barrs@eacr.org

cancer research, oncology, cancer cell signalling, cell signalling networks, cell signalling control mechanisms, cancer progression, cancer therapy resistance, post-translational protein regulation, transcriptional gene regulation, transcriptomics, proteomics, phosphoproteomics, kinases and phosphatases, signalling rewiring, signal integration, RNA biology in cancer